:: CLDF ::

Home | Contact Us | Bookmark

NASH

ALCOHOL LIVER DISEASE

PEDIATRIC LIVER DISEASE

Embassy of Education

Webcasts Abstract Library LiverQ Academy National Conference Regional Conferences

Public Health

Available Topics

11-25-2020	Patients cured of HCV still at high liver-cancer risk
09-12-2018	Bayer adds label warning to stomach relief drops
04-24-2018	REFILE-Almost 300 million worldwide may be infected with HBV
04-03-2018	Almost 300 million worldwide may be infected with HBV
12-05-2014	Pakistani blood transfusions spreading hepatitis, HIV: official
11-28-2014	Many IBD patients don't get hepatitis B vaccine: US study
11-28-2014	REFILE-Many IBD patients don't get hepatitis B vaccine: US study
11-27-2014	Colon neoplasia more common in UC-PSC than Crohn's-PSC
11-26-2014	Celiac disease showing up in many forms and at all ages
11-24-2014	Vitamin D, mortality may be linked in non-cirrhotic alcoholics
11-21-2014	Most heavy drinkers are not alcoholics, U.S. study finds
11-20-2014	France pegs Gilead hepatitis C drug at "lowest price in Europe"
11-11-2014	Sustained viral response to HCV meds bodes well for long-term survival
11-11-2014	Gilead hepatitis C drug highly effective in cirrhosis patients
11-10-2014	Merck four-week hep C regimen with Gilead's Sovaldi comes up short
11-06-2014	High-risk coronary plaque linked to common liver disease
10-27-2014	Maintenance opioid agonists protect against HCV in injection drug users
10-21-2014	Giving pricey hepatitis drug to prisoners may be financially wise
10-21-2014	REFILE-Giving pricey hepatitis drug to prisoners may be financially wise
10-15-2014	Unsaturated fats might offset heart risk from weight gain
09-15-2014	Gilead signs hepatitis C pact to cut drug cost for poor
09-03-2014	Even if you build a toilet, they may not come - water expert
09-01-2014	Increasing rates of acute hepatitis C infection among young Americans
08-28-2014	U.S. infant vaccination rates high, timeliness a concern -CDC
08-14-2014	Rifamycin-containing regimens may be preferable in latent tuberculosis
08-04-2014	U.S. hepatitis C burden may ease in coming decades: study
07-30-2014	Novartis drug clears malaria parasite in phase II study
05-08-2014	One billion people still defecate in public despite health risks-UN
04-18-2014	West African Ebola outbreak caused by new strain of disease: study
04-09-2014	WHO joins clamor to make new hepatitis C pills affordable
04-08-2014	Gilead aims to license hepatitis C drug to 3-4 Indian firms
04-02-2014	Costs to public of $84,000 hep C drug 'outrageous' - Kaiser
04-02-2014	Costs to public of $84,000 hep C drug 'outrageous' - Kaiser
03-13-2014	NY hospital warns patients of possible HIV, hepatitis exposure
03-04-2014	Passion for vodka kills Russian men in their 50s
01-07-2014	Most U.S. doctors fail to discuss alcohol with patients
01-03-2014	China says child deaths not linked to hepatitis vaccine
12-27-2013	Single injection of liposomal amphotericin cures visceral leishmaniasis
12-23-2013	China investigates after vaccine suspected in seven deaths
12-16-2013	Fight for cheap drugs shifts from AIDS to new hepatitis pills

HEPATITIS

HBV
HCV
HDV

CLD HEALTH OUTCOMES

CIRRHOSIS

Cirrhosis
HE
HRS
Thrombocytopenia

NASH

Slide Library
Publications
Webcasts
Abstract Library Committee Members

CHOLESTATIC

PBC

HCC

Slide Library
Publications
Webcasts
Algorithm
Abstract Library Committee Members

ALCOHOL LIVER DISEASE

Recorded Educational Webinar

PEDIATRIC LIVER DISEASE

Webcasts
Slide Library
Abstract Library

About CLDF

Board of Trustees
Board of Advisors/Faculty
CLDF Committees
2024 GI Fellow Board of Advisors

Other Resources

Journal Abstracts

The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2024 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.

Subscribe